Variable use of opioid pharmacotherapy for chronic noncancer pain in Europe: causes and consequences

Journal of Pain & Palliative Care Pharmacotherapy
Rafael Galvez

Abstract

According to the 2005 Pain in Europe Survey, the use of opioids to treat patients with chronic noncancer pain varies considerably among different countries in Europe. Undertreatment of chronic pain is common. This review examines the possible causes and consequences of limiting opioid availability to these patients. The causes of inadequate opioid use include medical, ethical, and cultural factors that influence prescribing decisions; legislative and health care system controls that serve to restrict the use of opioids for long-term treatment of non-cancer-related pain conditions; and poor treatment acceptance by patients. The validity of these restrictions is discussed in relation to the need to protect patients and society from harm due to adverse events, and the potential for misuse and abuse with prescribed opioids. This is balanced against the therapeutic goal of providing the best available pain-relieving treatment and to avoid the consequences of unnecessary suffering in patients with chronic noncancer pain.

References

Sep 1, 1991·Journal of Gastroenterology and Hepatology·M J LangmanN Yeomans
Dec 20, 1995·JAMA : the Journal of the American Medical Association·A R Jadad, G P Browman
Jul 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M SegasothyW M Bennett
Jan 20, 1996·Lancet·D E MoulinH Merskey
Apr 1, 1996·Journal of Pain and Symptom Management·R K Portenoy
Apr 1, 1996·Journal of Pain and Symptom Management·D C Turk
Feb 1, 1997·The Annals of Pharmacotherapy·M D McGoldrick, G R Bailie
Nov 6, 1998·Journal of Pain and Symptom Management·P L DellemijnJ A Vanneste
Jul 7, 1999·Lancet·H McQuay
Oct 27, 1999·Journal of Pain and Symptom Management·R AparasuT V Parasuraman
Feb 17, 2001·Current Opinion in Structural Biology·E ChevetJ J Bergeron
Feb 28, 2001·Journal of Pain and Symptom Management·D M NeighborsS L Dodd
May 12, 2001·BMJ : British Medical Journal·H McQuay
Sep 18, 2001·European Journal of Pain : EJP·P L Dellemijn
Mar 20, 2002·European Journal of Pain : EJP·E CatalàJ L Segú
Apr 17, 2002·Clinical Rheumatology·W A Katz
Aug 22, 2002·Clinical Pharmacology and Therapeutics·Fèlix Bosch, Josep E Baños
Jan 9, 2003·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Eldon Tunks
Mar 28, 2003·The New England Journal of Medicine·Michael C RowbothamDavid Mohr
Jul 10, 2003·Journal of Pain and Symptom Management·Seddon R SavageAaron M Gilson
Aug 26, 2003·European Journal of Pain : EJP·Harald Breivik
Aug 26, 2003·European Journal of Pain : EJP·Eija KalsoMichael Zenz
Nov 14, 2003·The New England Journal of Medicine·Jane C Ballantyne, Jianren Mao
Feb 19, 2004·British Journal of Anaesthesia·K H Simpson
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·C R GreenE Guerrero
Mar 2, 2005·European Journal of Pain : EJP·Harald Breivik
Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
Nov 29, 2005·European Journal of Pain : EJP·Anne M McDermottEllen M Dukes
Feb 21, 2006·European Journal of Pain : EJP·Kirsty HutchinsonRob Horne
Apr 18, 2006·Physical Medicine and Rehabilitation Clinics of North America·Donna Bloodworth
May 24, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Andrea D FurlanEldon Tunks
Oct 31, 2006·European Journal of Pain : EJP·Jette Højsted, Per Sjøgren
Dec 2, 2006·The Medical Journal of Australia·Delia SchafferKathleen M Curnow

❮ Previous
Next ❯

Citations

Nov 1, 2013·Der Anaesthesist·B KumleA Gries
Jul 7, 2011·Journal of Medical Economics·Andrés SternMaría Rull
Sep 21, 2011·Current Medical Research and Opinion·Eija Kalso
Jul 30, 2011·Pain Practice : the Official Journal of World Institute of Pain·Joseph PergolizziGeneroso Uomo
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Meredith NobleKaren M Schoelles
Oct 13, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Jonathan S JahrChristian C Apfel
Aug 7, 2021·Research in Social & Administrative Pharmacy : RSAP·Tanvee Thakur, Betty Chewning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.